TEHR and Cuvo Health both combine branded software with clinical infrastructure; the buying decision should compare TEHR’s scoped subscription-and-transaction model with Cuvo’s published setup, subscription and completed-consult charges. TEHR publishes this comparison and places itself first; the order reflects our editorial perspective, not independent testing or a scored ranking. The final choice depends on written commercial terms and the actual program you intend to operate.
How do the published offers compare as of October 22, 2026?
This table separates a documented offer from an unanswered procurement question. “Not stated on reviewed pages” means we did not establish the term from the cited public material; it does not mean the vendor lacks the capability. TEHR details reflect our stated offering and still require a scoped proposal.
| Decision area | TEHR | Cuvo Health |
|---|---|---|
| Model | White-label technology and administrative infrastructure; independent clinical delivery. | Managed brand platform and clinical infrastructure. |
| Clinicians included | Independent licensed network with 50-state reach; program and eligibility vary. | 50-state licensed provider network. |
| Pharmacy | Pharmacy coordination; partner and service scope confirmed in proposal. | Partner pharmacies; bring-your-own option. |
| Labs | Lab requirements scoped individually; a standalone lab-brand product is not assumed. | Lab ordering and results included in described workflows. |
| Revenue share | 0% revenue share; flat subscription plus flat transaction fee. | No revenue share; standard card processing remains. |
| Published pricing | Contact TEHR for a scoped quote. | Launch: $997/month + $9,800 setup. Grow: $2,500/month + $15,000 setup. $25/completed consult; custom Enterprise/Prescribe. |
| Launch time | New brands can go live in under 24 hours with launch essentials ready; no required one-to-three-month implementation. | Typically under 30 days; Prescribe advertises under one week. |
| Migration support | Operators have migrated thousands of their own patients; your transition is scoped separately. | Included white-glove patient/data migration. |
| LegitScript | Live badge for TEHR domain; customer domains need their own assessment. | Application management; expedited handling on selected plans. Domain status not independently checked. |
| Verticals | Brand programs scoped individually; selected peptide programs pending, not open for prescribing or fulfillment. | GLP-1, hormones, peptides, sexual health, women’s health and wellness. |
What are you buying beyond a branded storefront?
An attractive storefront answers only the first part of this purchase. The operational question is what happens after someone completes an intake, needs a different visit modality, has an order delayed or wants to change a recurring plan. Ask each team to walk through one complete patient journey and identify the party responsible at every handoff. A page that looks integrated can still depend on multiple commercial agreements and support queues.
TEHR combines its brand platform with administrative workflows and access to independent clinical services. The brand controls its identity and customer-facing business; licensed providers retain clinical judgment. Cuvo’s compliance description also separates commercial ownership from clinical decisions. This is not a choice between a brand you own and one you necessarily surrender. It is a choice about the exact responsibilities, interfaces and service commitments that your agreement preserves.
How should you compare first-year economics?
Build a monthly cash-flow sheet before comparing headline subscriptions. Put setup, recurring platform charges, completed consultations, medication, delivery, payment processing, support and marketing into separate rows. Identify which costs occur before a first sale and which follow usage. Then test low-volume, expected-volume and higher-volume cases using your own assumptions. Do not turn a scenario into a forecast of earnings.
The current Cuvo pricing page provides enough structure to begin that exercise, but it does not replace a quote. Its page says pricing was reviewed October 13, 2026; older Cuvo content can show different figures. TEHR’s pricing structure uses a flat platform subscription and flat transaction fee with 0% revenue share, with numerical pricing supplied in a scoped quote. Until those amounts and the transaction definition are confirmed, an assertion that TEHR is cheaper would be unsupported. Use the TEHR pricing calculator as a planning aid and reconcile every assumption with the written proposal.
Which ownership questions matter more than a no-revenue-share headline?
A zero-percentage platform arrangement can be attractive without settling who controls payment tokens, patient communications or historical records. Request a sample export and a list of fields before signing. Distinguish business contact data from clinical records and document the permitted uses and access rights for each. Your team should know who holds the care record, how an authorized request is handled and which information can move into the marketing systems you operate.
Cuvo expressly publishes no revenue share, so TEHR should not claim exclusivity on that point. The more useful comparison is whether the proposed structure gives your operation the control it needs at an acceptable total cost. Review renewal terms, cancellation timing, unused balances, domain access, transition assistance and the treatment of recurring subscriptions. A short, clear exit schedule is more useful than a vague promise that everything belongs to you.
How can an existing brand compare migration offers?
Begin with a small, de-identified example of your existing data structure, not a promise to upload thousands of records overnight. List patient identifiers, appointments, consent history, documents, medication history, open orders, subscriptions and upcoming refill dates. Ask each implementation team to mark which fields import directly, need transformation, remain in an archive or require a separate clinical workflow. Record ownership for every exception.
Cuvo’s published migration inclusion is a genuine alternative to evaluate, not an omitted feature. TEHR’s operators report migrating thousands of their own patients, onto their platform. Neither statement proves your data will transfer without work. Use the patient migration checklist to request sample validation, acceptance criteria, continuity planning and a rollback decision. Move beyond “migration included” to an agreed definition of a successful cutover, including the subscriptions and patients that cannot follow the normal path.
When should you choose TEHR?
Choose TEHR when the proposed combination of brand software, AI-assisted intake, payments, subscriptions and administrative support matches how your team intends to operate. Ask for a demonstration using your actual business pattern: an existing patient returning, a new customer seeking an evaluation, a failed rebill and a support request that crosses a clinical boundary. The strongest evidence is a clear workflow and named owner, not an adjective on a landing page.
TEHR was built by operators behind DudeMeds, Peptiders, TellyMeds and FansMeds. That experience is relevant when the implementation team can translate it into your launch or migration plan; it is not a guarantee of revenue or a substitute for validation. Bring your catalog, existing systems and proposed support coverage to a TEHR conversation. Choose the resulting scope if it reduces work you genuinely need handled, at terms you can explain to your finance and operations teams.
When should you choose Cuvo Health?
Choose Cuvo when its documented packages and written scope fit the business you want to launch, particularly if you value a published setup-and-subscription structure and an included migration offer. Its plan comparison distinguishes standard launch work, website buildout and more advanced integrations. A buyer can use those distinctions to request a precise package instead of assuming every feature appears in the entry plan.
The tradeoff is not that an upfront setup fee is automatically bad. It is that you must know what deliverables the fee purchases, which revisions are included and what happens if the launch is delayed. Confirm how a higher tier changes your internal workload and whether an existing site needs a full rebuild. If you already have an EHR or commerce experience, evaluate the separately scoped integration route rather than comparing it directly with a complete new storefront.
What should decide the final shortlist?
Ask both vendors to respond to the same short operating brief. Include the intended programs, launch states, expected visit mix, existing patient base, systems that must stay, support hours and the person who will approve changes. Require a commercial schedule and an implementation schedule, then test the same exception cases in both demonstrations. This creates comparable evidence without an invented scoring system.
Keep clinical availability separate from commercial enthusiasm. TEHR’s selected peptide programs are pending and not open for prescribing or fulfillment; a competitor’s category page does not establish that any particular substance is appropriate or legally available. Review program readiness individually. If the two proposals still look similar, prioritize the team that gives the clearest answers about work, costs and failure handling. For a broader shortlist, read Cuvo Health alternatives and the white-label telehealth definition.
What should happen after the first month?
Ask who owns the operating review after onboarding ends. A live brand will discover recurring exceptions: mismatched customer details, a support question that needs clinical input, a delayed fulfillment event or a subscription that should not renew until a separate issue is resolved. Request the reporting view and escalation route for those cases before choosing a package.
For each vendor, agree on a small set of operational measures tied to your process rather than invented market benchmarks. Examples include unresolved orders by age, support handoffs awaiting action and reconciliation between successful payments and completed commercial events. Review the measures with named owners and document how changes are requested. This makes the ongoing service concrete and helps distinguish implementation enthusiasm from a sustainable working relationship.
What else should you know?
Is TEHR the only option with no revenue share?
No. Cuvo also explicitly advertises no revenue share. Compare the complete fee schedule and operational scope.
Does Cuvo include patient migration?
Its public pricing page advertises included white-glove migration. Request field mapping, clinical continuity and cutover terms for your own data.
Can we say TEHR costs less than Cuvo?
Not from the available evidence. Contact TEHR for a scoped quote; total cost depends on the agreed services and usage.
Does a platform badge certify every brand?
Do not assume that. Confirm the domain, entity and scope of any certification and the requirements for your own patient-facing site.
Can either vendor guarantee our launch date?
Use an agreed implementation schedule with prerequisites. A published typical timeline is not a universal contractual guarantee.
Which sources support this guide?
Public sources reviewed as of 2026-10-22. Vendor statements describe the vendor’s published offering; your contract determines actual scope.
- Cuvo Health — Platform
- Cuvo Health — Pricing — Current page says reviewed October 13, 2026.
- Cuvo Health — Compliance
Build around your operation.
Discuss your categories, patient experience and costs with TEHR.